Differential Regulation of Growth Plate Chondrocytes by 1α,25-(OH)2D3and 24R,25-(OH)2D3 Involves Cell-maturation-specific Membrane-receptor-activated Phospholipid Metabolism
Open Access
- 1 March 2002
- journal article
- review article
- Published by SAGE Publications in Critical Reviews in Oral Biology & Medicine
- Vol. 13 (2) , 143-154
- https://doi.org/10.1177/154411130201300205
Abstract
This review discusses the regulation of growth plate chondrocytes by vitamin D3. Over the past ten years, our understanding of how two vitamin D metabolites, 1α,25-(OH)2D3 and 24R,25-(OH)2D3, exert their effects on endochondral ossification has undergone considerable advances through the use of cell biology and signal transduction methodologies. These studies have shown that each metabolite affects a primary target cell within the endochondral developmental lineage. 1α,25-(OH)2D3 affects primarily growth zone cells, and 24R,25-(OH)2D3 affects primarily resting zone cells. In addition, 24R,25-(OH)2D3 initiates a differentiation cascade that results in down-regulation of responsiveness to 24R,25-(OH)2D3 and up-regulation of responsiveness to 1α,25-(OH)2D3. 1α,25-(OH)2D3 regulates growth zone chondrocytes both through the nuclear vitamin D receptor, and through a membrane-associated receptor that mediates its effects via a protein kinase C (PKC) signal transduction pathway. PKCα is increased via a phosphatidylinositol-specific phospholipase C (PLC)-dependent mechanism, as well as through the stimulation of phospholipase A2 (PLA2) activity. Arachidonic acid and its downstream metabolite prostaglandin E2 (PGE2) also modulate cell response to 1α,25-(OH)2D3. In contrast, 24R,25-(OH)2D3 exerts its effects on resting zone cells through a separate, membrane-associated receptor that also involves PKC pathways. PKCα is increased via a phospholipase D (PLD)-mediated mechanism, as well as through inhibition of the PLA2 pathway. The target-cell-specific effects of each metabolite are also seen in the regulation of matrix vesicles by vitamin D3. However, the PKC isoform involved is PKCζ, and its activity is inhibited, providing a mechanism for differential autocrine regulation of the cell and events in the matrix by these two vitamin D3 metabolites.Keywords
This publication has 83 references indexed in Scilit:
- Arachidonic acid induces differentiation of uterine stromal to decidual cellsEuropean Journal of Cell Biology, 1999
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- 1β, 25(OH)2-vitamin D3 is an antagonist of 1α,25(OH)2-vitamin D3 stimulated transcaltachia (The rapid hormonal stimulation of intestinal calcium transport)Biochemical and Biophysical Research Communications, 1992
- Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reactionBiochemical and Biophysical Research Communications, 1989
- Formation of diacylglycerol by a phospholipase D-phosphatidate phosphatase pathway specific for phosphatidylcholine in endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Developmental changes in responsiveness to vitamin D metabolitesJournal of Steroid Biochemistry, 1987
- Localization of collagenase in the growth plate of rachitic rats.Journal of Clinical Investigation, 1985
- Endocytic activity and ultrastructural cytochemistry of lysosome-related organelles in epiphyseal chondrocytesJournal of Ultrastructure Research, 1981
- Specific nuclear uptake of 24,25‐dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilageFEBS Letters, 1980
- The lipids of matrix vesicles from bovine fetal epiphyseal cartilageCalcified Tissue International, 1974